| Breakdown | TTM | Dec 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 373.00K | 1.28M | 1.14M | 173.00K | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 1.14M | 0.00 | 0.00 | 0.00 |
| EBITDA | 15.32M | 18.23M | 0.00 | 1.15M | 84.56M | 20.93M |
| Net Income | 15.30M | 17.37M | -10.12M | 1.15M | 84.66M | -7.90M |
Balance Sheet | ||||||
| Total Assets | 111.78M | 117.38M | 98.90M | 113.75M | 134.23M | 36.53M |
| Cash, Cash Equivalents and Short-Term Investments | 8.13M | 29.61M | 42.64M | 79.06M | 131.90M | 652.00K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.18M | 1.08M | 386.00K | 1.06M | 290.00K | 3.42M |
| Stockholders Equity | 110.60M | 116.30M | 98.51M | 112.70M | 133.94M | 33.11M |
Cash Flow | ||||||
| Free Cash Flow | -481.00K | -784.00 | -1.32M | -795.00K | -2.75M | 398.00K |
| Operating Cash Flow | -481.00K | -784.00 | -1.32M | -795.00K | -2.75M | 398.00K |
| Investing Cash Flow | -2.00K | -12.53M | -32.35M | -29.65M | 119.30M | 0.00 |
| Financing Cash Flow | -21.00M | -1.03M | -2.75M | -22.39M | 14.70M | -108.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £726.72M | 13.13 | 21.11% | 2.16% | 7.13% | 17.31% | |
71 Outperform | £262.48M | 4.85 | 11.00% | 4.85% | 25.24% | 19.81% | |
64 Neutral | £72.22M | 85.60 | 4.97% | 2.25% | -15.64% | -22.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
49 Neutral | £57.61M | 1.20 | 28.14% | ― | ― | ― | |
46 Neutral | £88.18M | -2.27 | -7.68% | 8.43% | 0.38% | -273.53% | |
40 Underperform | £1.60M | -0.05 | -52.46% | ― | 11.78% | -39.58% |